FORM 8-K

Company

GT Biopharma, Inc.

Filed

April 12, 2000

Period of Report

March 6, 2000

Accession Number

0001032210-00-000717

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →